1st Jun 2015 06:46
LONDON (Alliance News) - Drug research services company Cyprotex PLC on Monday said trading in the first five months of 2015 was ahead of its expectations and said it now expects its full-year results to beat market forecasts.
In a short trading update, Cyprotex said its financial performance in the first five months of the year has been ahead of its expectations, with strong UK revenue growth outpacing continued challenges in its US operation.
As a result, it said it expects its profit and revenue for the year to be ahead of market expectations. According to Morningstar, brokers currently expect Cyprotex to post a pretax loss GBP0.2 million for 2015.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CRX.L